Clinical trials
Glaucoma clinical trials
Below are recruiting glaucoma clinical trials, each written for real people, not researchers. We’re tracking 209 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06465537Recruiting
Gene editing therapy for glaucoma with MYOC mutation
This trial is testing a one-time gene-editing treatment for people with glaucoma caused by a MYOC gene mutation. The goal is to lower eye pressure and possibly reduce the need for eye drops.
Beijing, Beijing MunicipalityAges 18–65 - NCT06549010Recruiting
Virtual reality vision test for healthy eyes and glaucoma
This study tests a new virtual reality device to measure your field of vision (how well you see at the edges). It will compare the VR test to the standard bowl test. If you have healthy eyes or glaucoma, you may be able to join.
Chicago, IllinoisAges 25–70 - NCT06577857Recruiting
Long-term follow-up for MIMS eye procedure
This study is checking on people who had a specific eye surgery called MIMS at least two years ago. It aims to see how they are doing over time.
YerevanAges 40–85 - NCT06593405RecruitingEarly Phase 1
Occupational therapy for eye disease medication management
This trial tests whether occupational therapy can help people with age-related macular degeneration (AMD), diabetic retinopathy (DR), or glaucoma better manage their medications. Participants share their deidentified data to see if therapy improves outcomes.
Worcester, MassachusettsAges 50–100 - NCT06841575Recruiting
Better eye imaging for children and adults at Duke
This study tests a new camera that automatically adjusts to take clear pictures of the back of the eye. It aims to improve retinal imaging for healthy adults, adult eye clinic patients, and children seen at Duke Eye Center.
Durham, North CarolinaAges 1 month+ - NCT06848946RecruitingPhase 4
Eye implant with cataract surgery vs. cataract surgery alone
This trial tests if a tiny implant called iDose® TR, placed during cataract surgery, can better control eye pressure in people with glaucoma or high eye pressure compared to cataract surgery alone.
Kenosha, WisconsinAges 45 years+ - NCT06883123RecruitingPhase 4
Comparing two glaucoma drop combinations
This study compares two different pairs of glaucoma eye drops to see which works better. If you are currently using Cosopt and Latanoprost, you may be able to switch to Simbrinza and Rocklatan or stay on your current drops.
Springfield, IllinoisAges 18 years+ - NCT06943599Recruiting
Improving Eye Care After Screening
This study looks at better ways to help people get follow-up eye care after a screening. If you were in the VIEW II study and were referred to an eye hospital, this trial may offer strategies to support you in getting that care.
San Francisco, CaliforniaAges 60 years+ - NCT06953349Recruiting
Surgery systems with cataract and glaucoma treatment
This trial looks at how well certain surgical systems work when combined with cataract surgery and a glaucoma procedure. It may help people with glaucoma who need fewer medications after surgery.
Mesa, ArizonaAges 18 years+ - NCT07015034Recruiting
Preventing vision loss in older adults with chronic conditions
This study tests a model to help general practitioners find older patients who may be at risk of vision loss. It aims to spot problems early so treatment can start sooner.
Copenhagen, Capital RegionAges 70 years+ - NCT07075718RecruitingPhase 2/Phase 3
Evaluating a new travoprost eye implant for glaucoma
This trial tests a newer version of a tiny implant placed inside the eye to lower pressure in people with open-angle glaucoma or ocular hypertension. It may offer a treatment option that doesn't require daily eye drops.
Grand Junction, ColoradoAges 18 years+ - NCT07135570Recruiting
My Eyes, My Light: Amar Chokh, Amar Alo
This trial is studying people living in Char Fasson, Bangladesh, to see who might have undiagnosed eye problems. It's a local screening program to catch eye issues early.
Char Fasson, BholaAges 35 years+ - NCT07145073Recruiting
Brain stimulation for vision loss from glaucoma
This study tests if a gentle electrical current applied to the scalp can improve vision in people with glaucoma. It uses a type of non-invasive brain stimulation called rtACS, which may help damaged optic nerves work better.
Taipei, HawaiiAges 18 years+ - NCT07149740Recruiting
A study to collect images of eyes for new camera technology
This trial uses a special camera (OCT) to capture detailed images of the eye. It aims to improve eye disease detection. You may join if you have retinal disease, glaucoma, corneal disease, or healthy eyes.
Anaheim, CaliforniaAges 22 years+ - NCT07218783RecruitingPhase 3
Testing a new glaucoma implant with cataract surgery
This trial tests a new implant that releases medicine for glaucoma while you have cataract surgery. It may help lower eye pressure without using daily drops.
Houston, TexasAges 22 years+ - NCT07218796RecruitingPhase 3
Bimatoprost implant with IOL vs. timolol drops for glaucoma
This trial tests if a bimatoprost implant placed during cataract surgery (combined with a special lens) can lower eye pressure better than standard timolol eye drops. It may help people with mild to moderate glaucoma or high eye pressure who are already planning cataract surgery.
San Antonio, TexasAges 22 years+ - NCT07235592Recruiting
Preserflo MicroShunt study for open-angle glaucoma
This trial is testing a small device called the PRESERFLO MicroShunt to lower eye pressure in people with open-angle glaucoma. It may be an option if your eye pressure stays high even with maximum eye drops.
ViennaAges 18–85 - NCT07325552Recruiting
Comparing two glaucoma surgeries with cataract surgery
This trial tests which of two micro-surgeries for glaucoma works better when you're also having cataract surgery. It may help you if you have both cataracts and glaucoma and take eye drops to control eye pressure.
Bialystok, PolskaAges 4 months+ - NCT07341763Recruiting
Brain stimulation for better mobility in vision loss
This study tests whether a safe, noninvasive brain stimulation technique (called tDCS) can help people with vision loss from retinitis pigmentosa, rod-cone dystrophy, or advanced glaucoma move around more easily and safely. Participants will do walking and orientation tasks while receiving the stimulation.
Waterloo, OntarioAges 18 years+ - NCT07359547Recruiting
Comparing Two Glaucoma Drainage Devices
This trial compares two different tiny drainage devices (a gel stent and a microshunt) for lowering eye pressure in people with certain types of glaucoma that are not well controlled with medications. The goal is to see which device works better and is safer.
Leuven, Vlaams-brabantAges 40 years+ - NCT02014389Recruiting
Testing pupil measurements with colored light in eye exams
This study checks how well a device can measure how your pupils respond to colored light. It may help improve eye testing, especially when monitoring certain vision and nerve conditions.
Tel LitwinskyAges 18–80 - NCT02157025Recruiting
Better vision test for kids with glaucoma concerns
This study tries a more engaging way to test children’s vision using a visual field exam, to make the results more reliable. It may help your child practice the test better over two visits and give the clinic more dependable information.
Fort Lauderdale, FloridaAges 5–8 - NCT02290795Recruiting
Study of the eye nerve shape in glaucoma and other eye conditions
This study looks at how parts of the eye’s optic nerve and retinal surface look and change in people with glaucoma (or certain eye procedures) and in healthy volunteers. It may help researchers better understand eye anatomy, which could guide future care.
LeuvenAges 18 years+ - NCT03011541Recruiting
Stem cell treatment for damaged retina or optic nerve
This study looks at stem-cell treatment to help vision in adults whose retina or optic nerve damage is not expected to improve on its own. You may be a candidate if your eye exam shows documented, stable or slowly changing damage and you can safely complete follow-up eye visits.
Westport, ConnecticutAges 18 years+
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for glaucoma?
- Yes. Clin2 currently lists 209 recruiting glaucoma studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a glaucoma trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a glaucoma trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.